ReAlta Life Sciences, Inc. appointed Howard Berman, Ph.D., as Executive Chairman of its Board of Directors. Dr. Berman brings over 20 years of experience in biopharmaceutical leadership, particularly in immunology and neuroscience. His expertise positions ReAlta for growth in rare and inflammatory diseases, according to company statements. He previously founded Coya Therapeutics, Inc. and serves on the board of Atea Pharmaceuticals, Inc.

Read more at Yahoo Finance: ReAlta Life Sciences Designates Dr. Howard Berman as Executive Chairman